The experience of neoadjuvant chemotherapy versus upfront surgery in resectable pancreatic cancer: a cross sectional study

BACKGROUND: Upfront resection (UR) followed by adjuvant chemotherapy remains the standard treatment for resectable pancreatic cancer. There is increasing evidence suggesting favourable outcomes toward neoadjuvant chemotherapy (NAC) followed by surgery. METHODS: All clinical staging with resectable p...

Descripción completa

Detalles Bibliográficos
Autores principales: Su, Yung-Yeh, Chao, Ying-Jui, Wang, Chih-Jung, Liao, Ting-Kai, Su, Ping-Jui, Huang, Chien-Jui, Chiang, Nai-Jung, Yu, Yu-Ting, Tsai, Hong-Ming, Chen, Li-Tzong, Shan, Yan-Shen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10498854/
https://www.ncbi.nlm.nih.gov/pubmed/37300888
http://dx.doi.org/10.1097/JS9.0000000000000495

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10498854/
https://www.ncbi.nlm.nih.gov/pubmed/37300888
http://dx.doi.org/10.1097/JS9.0000000000000495

Ejemplares similares